Efficacy and Safety of Selumetinib in Adults with Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas (komet): A Multicentre, International, Randomised, Placebo-controlled, Parallel, Double-blind, Phase 3 Study

Chen, Alice P, Coyne, Geraldine O'Sullivan, Wolters, Pamela L, Martin, Staci, Farschtschi, Said, Blanco, Ignacio, Zhongping, Darrigo, Luiz Guilherme, Eoli, Marica, Whittle, James R, Nishida, Yoshihiro, Lamarca, Rosa, de la Rosa Rodriguez, Randolph, Adeyemi, Ayo, Herrero, Idoia, Llorente, Nereida, Diede, Scott J, Dombi, Eva, Wolkenstein, Pierre, Lee, Alexander, Mastronuzzi, Angela, Swampillai, Bokhyan, Beniamin, Van Tine, Brian, Barnett-Tapia, Carolina, Matthies, Cordula, Shuhaiber, Hans, Styczynski, Jan, Sepulveda Sanchez, Juan M., Fertitta, Laura, Severino-Freire, Maëlla, D'Agostino, Maria D., Dorofeeva, Marina, Schuhmann, Liu, Pinan, Nakayama, Robert, Perez Pereira, Rodrigo, Perrotta, Silverio, Sonaglio, Viviane, Gao, Xinghua, Berman, Yemima, Zhu, Yicheng, Nobeyama, Yoshimasa